bchow

@HeartInstitute @KateyRayner Congratulations to Yellowbird and the University of Ottawa Heart Institute. Working together to improve patient diagnosis and patient care. #no_more_FDG

In partnership with Yellowbird Diagnostics, we are launching a groundbreaking Phase 1 clinical trial on NeuCaVis, a new PET imaging agent designed to visualize inflammation throughout the body. We’re recruiting healthy volunteers. 👉 Details: neucavis.com

Congratulations to Dr Ihdayhid for winning the Best Abstract at SCCT. Honoured to be able collaborate with him and team.

Congratulations Alyssa for passing the USMLE Step 1.

#Canadiannice. cnn.com/2020/12/07/us/…

Congratulations Soroush. Could even be beneficial in the COVID-19 era. By eliminating rest imaging (reducing test duration), it also allows us to maximize opportunities for ‘time/physical distancing’ thereby improving safety of patients and staff.

Seven minutes to change the world for underserviced and remote populations - University of Ottawa Heart Institute ottawaheart.ca/the-beat/2020/…

1st ‘Elf on a shelf’, now ‘Deer with a beer’

Thank you TD, for helping us help others.

Meet the 2019 #TDReadyChallenge recipients innovating to unlock improved health outcomes in communities across North America. go.td.com/2DEErzj

Hoping that this article will encourage discussion about CBME in cardiac imaging.

Congratulations Samiya! AI research at UOHI and successfully defended her thesis at Universite Mohammed V.

@DrJRamchand @venkmurthy @alialshahrani @hachamr @ZainabASamad Thanks everyone for a great JC. #CircImgJC

@venkmurthy @alialshahrani @bchowmd @hachamr @ZainabASamad I think having the skillset in both fields is useful for deep phenotyping of inherited cardiac conditions. I am particularly interested in cardiomyopathies and related phenotypes and am now working on a large cohort of patients with suspected ‘LVNC’ #CircImgJC

#CircImgJC Question 2: tell us about your background and how you got interested in these questions? @alialshahrani @bchowmd @hachamr @DrJRamchand @hachamr @ZainabASamad

@cshenoy3 @alialshahrani @CircImaging @DrJRamchand @ZainabASamad @venkmurthy @hachamr We do plan to further validation and looking at 'outcomes' If there are collaborators out in the 'twitter-verse' who are interest, drop me a line. #CircImgJC

Welcome to Oct 2019 #CircImgJC on “Point of Care Clinical Risk Score to Improve the Negative Diagnostic Utility of an Agatston Score of Zero” (ahajournals.org/doi/10.1161/CI…) w/ @alialshahrani @bchowmd @DrJRamchand @hachamr moderated by @ZainabASamad & me.

@venkmurthy @alialshahrani @hachamr @DrJRamchand @ZainabASamad Seriously, it is all about finding a good mentor who is enthusiastic and willing to ensure your success. #CircImgJC

@venkmurthy @alialshahrani @hachamr @DrJRamchand @ZainabASamad Come to Ottawa...hahahaha (it is cold, but a good time) #CircImgJC

#CircImgJC Question 3: What advice do you have for fellows and trainees interested in research? @alialshahrani @bchowmd @hachamr @DrJRamchand @ZainabASamad

@hachamr @venkmurthy @DrJRamchand @ZainabASamad @alialshahrani Agree. There is huge variability between individuals/clinicians/healthcare professionals when taking a history. Standardization would be great, but often there are subtle 'nuances' when interacting with patients. #CircImgJC

@bchowmd @venkmurthy @DrJRamchand @ZainabASamad @alialshahrani anginal sx are a problematic variable. An enormous breakthrough would be to use the SAQ in all pts to get a better grip on the sx and its implications

@venkmurthy @DrJRamchand @ZainabASamad @hachamr @alialshahrani This would be an interesting sub-analysis. Perhaps we should go back and look at women specifically and see of different CP/dyspnea/symptoms could be used in a model specific to women. #CircImgJC

@bchowmd @DrJRamchand @ZainabASamad @hachamr @alialshahrani This is a great point! We are often told to think about atypical sx, esp in women. What does this data imply about that suggestions? #CircImgJC

@DrJRamchand @ZainabASamad @venkmurthy @hachamr @alialshahrani Unfortunately, 'non-typical CP' and dyspnea etc were not 'predictors' in the model. At this point, based on our analysis, we can only include 'typical' CP.

@ZainabASamad @venkmurthy @hachamr @alialshahrani @bchowmd I would like to know how ‘atypical’ chest pain or angina equivalent symptoms should be handled in this model. Currently the risk score gives a score of 5 for ‘typical‘ CP but doesn’t really account for the atypical symptoms #CircImgJC

@venkmurthy @hachamr @alialshahrani Very interesting question. We did not look at this specifically, however, we have previously published on the 'power of 0'. Patients with Agatston Score = 0, do not have L main or 3VD. #CircImgJC

@bchowmd @hachamr @alialshahrani That is a difficult question! What fraction had LM/3VD/pLAD? #CircImgJC

@hachamr @venkmurthy @alialshahrani Even if it were not to alter Rx, diagnosis in itself is often important to patients. Refuting the diagnosis of CAD may be reassuring to some. #CircImgJC

@bchowmd @venkmurthy @alialshahrani this is prevalence. atherosclerosis is present, but prob low risk. if the risk was low, and would be further lowered by Rx, what is the gain by testing (if Rx is given)